Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02289222
Title Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ashraf Badros
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Greenebaum Cancer Center at University of Maryland Medical Center Baltimore Maryland 21201-1592 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field